← All companies

AKTS — Aktis Oncology, Inc.

Materials · Pharmaceutical Preparations · Nasdaq

CIK 0002035832 · FYE 1231 · All Form 4 filings on EDGAR ↗

2Insiders filing
10Transactions
+$430kReported buys
−$2.8MReported sells
0Cluster events

Window in data: 2026-07-08 → 2026-07-08 · Data as of 2026-08-28

Insiders

InsiderRoleTxnsReported value
Czibere AkosChief Medical Officer5$1.6M
Ron-Bigger ShulamitChief Operating Officer5$1.6M

Transaction history

Filing dateTrade dateTickerInsiderTypeSharesPriceValueCluster
2026-07-102026-07-08AKTSRon-Bigger Shulamit Chief Operating OfficerM routine50,000$3.66+$183k
2026-07-102026-07-08AKTSRon-Bigger Shulamit Chief Operating OfficerS15,800$27.13−$429k
2026-07-102026-07-08AKTSRon-Bigger Shulamit Chief Operating OfficerS30,000$27.94−$838k
2026-07-102026-07-08AKTSRon-Bigger Shulamit Chief Operating OfficerS4,200$28.75−$121k
2026-07-102026-07-08AKTSRon-Bigger Shulamit Chief Operating OfficerM routine50,000
2026-07-102026-07-08AKTSCzibere Akos Chief Medical OfficerM routine50,000$4.95+$248k
2026-07-102026-07-08AKTSCzibere Akos Chief Medical OfficerS14,800$27.13−$401k
2026-07-102026-07-08AKTSCzibere Akos Chief Medical OfficerS30,829$27.95−$862k
2026-07-102026-07-08AKTSCzibere Akos Chief Medical OfficerS4,371$28.71−$125k
2026-07-102026-07-08AKTSCzibere Akos Chief Medical OfficerM routine50,000